CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that Dr. James B. Wyngaarden has chosen to retire from the Company’s Board of Directors after 21 years of dedicated service. Dr Wyngaarden was a founding Board member of Idera and has served in various capacities, including Chairman of the Board.
